In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  tegafur-uracil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: HGCSG-CAD, NCT00209742

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor: Other
Protocol IDs: JCOG-0205-MF, C000000193, NCT00190515

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor: Other
Protocol IDs: YCU-BRI-HN-05-01, NCT00336947

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: TMDU-BRI-CC-05-01, NCT00392899

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: MCSGO-CCTG-0501, NCT00385970

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: TMDU-TRICC0706, TRICC0706, NCT00660894

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: COLOCROSS, NCT00905047

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16964G

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16966C

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 75 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067511, E-1299, NCT00004860

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor: Other
Protocol IDs: BMS-200604, UMCC 0110g, NCT00037089

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR200025-001, NCT00439517

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 950914, NCT00464919

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 940813, TTY-TU0510, NCT00519688

15.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: TRIBC1009, NCT01262274

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CRC-SNU-2011-01, NCT01409005

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-96025, BMS-MSKCC-96025, NCI-V96-0942, NCT00002801

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067112, P30CA022453, WSU-D-1641, WSU-04-28-98-M02-FB, NCI-G99-1526, NCT00003925

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: TMDU-BRI-CC-05-02, BRI-CC-05-02, NCT00898846
New Search